# Protocol 1 — Opioid-Free GA + PECS/Serratus Blocks  
### Post-Mastectomy Breast Implant Revision  
**Preferred Pathway** • Version 1.0 — December 2025  

[![License: CC BY 4.0](https://img.shields.io/badge/License-CC%20BY%204.0-lightgrey.svg)](https://creativecommons.org/licenses/by/4.0/)

---

## Why This Is the Preferred Pathway
- Highest-quality analgesia (blocks + multimodal IV)  
- Lowest PONV risk (typically <5%)  
- Zero intraoperative opioids  
- Smooth, calm emergence  
- Ideal for capsular contracture, infection washout, anxious patients, or high Apfel scores  

---

## Indications
- Post-mastectomy implant revision (any etiology)  
- Baker Grade III–IV capsular contracture  
- Suspected/confirmed implant infection  
- High PONV risk (Apfel ≥3)  
- Patient request for opioid-free care  
- Extensive pocket work anticipated  

---

## Contraindications

| Absolute                  | Relative                                      |
|---------------------------|-----------------------------------------------|
| Local infection at site   | Therapeutic anticoagulation (discuss risk)    |
| True local anesthetic allergy | Severe COPD / CO₂ retention                |
| Patient refusal           | Baseline HR <50 (avoid dexmedetomidine bolus) |
|                           | Significant hepatic dysfunction (lidocaine)  |

---

## Required Equipment
- High-frequency linear ultrasound + sterile sleeve  
- 22G 80–100 mm block needle  
- Local anesthetic: **0.25–0.5% bupivacaine** or **0.2–0.375% ropivacaine**  
- Dexamethasone 4 mg (add to block for prolongation)  
- Standard ASA monitors + processed EEG (optional)  

---

## Preoperative Preparation

| Medication                  | Dose                           | Notes                                      |
|-----------------------------|--------------------------------|--------------------------------------------|
| Acetaminophen               | 1000 mg PO                     |                                             |
| Celecoxib                   | 200–400 mg PO                  | If no renal/GI contraindications           |
| Gabapentin (optional)       | 300–600 mg PO                  | Reduces anxiety & postoperative pain       |
| Midazolam (optional)        | 1–2 mg IV in block room        | Only if very anxious                       |
| Antibiotic prophylaxis      | Cefazolin 2–3 g IV (or alternative) | <60 min pre-incision                 |

---

## Regional Block Technique (Perform Before Induction)

### PECS I + II (Most Common)

| Block      | Target Interface                              | Volume         | Structures Covered                     |
|------------|-----------------------------------------------|----------------|----------------------------------------|
| PECS I     | Between pectoralis major & minor              | 10 mL          | Medial/lateral pectoral nerves         |
| PECS II    | Between pectoralis minor & serratus anterior  | 20 mL          | T2–T6 lateral + long thoracic nerve    |

### Serratus Anterior Plane Block (Alternative)
- Injection plane: superficial or deep to serratus at mid-axillary line (T4–T6 level)  
- Volume: **25–30 mL**  
- Excellent for lateral chest wall / axillary tail coverage

**Add-on:** Dexamethasone 4 mg to each block → extends duration 8–12 hours

---

## Induction Sequence (Opioid-Free)

| Step | Agent                     | Dose                          | Purpose                              |
|------|---------------------------|-------------------------------|--------------------------------------|
| 1    | Lidocaine                 | 1–1.5 mg/kg IV                | Blunts sympathetic response          |
| 2    | Propofol                  | 1.5–2 mg/kg IV                | Induction                            |
| 3    | Ketamine                  | 0.2–0.3 mg/kg IV              | Analgesia, hemodynamic stability     |
| 4    | Rocuronium                | 0.6–1.0 mg/kg (if ETT)        | Muscle relaxation                    |
| 5    | Airway                    | LMA (preferred) or ETT        |                                      |

---

## Maintenance of Anesthesia

| Component                  | Regimen                                      |
|----------------------------|----------------------------------------------|
| Volatile agent             | Sevoflurane 0.8–1.2 MAC **OR**               |
| TIVA                       | Propofol 75–125 mcg/kg/min                   |
| Dexmedetomidine            | 0.2–0.6 mcg/kg/hr (**no loading bolus**)     |
| Lidocaine infusion         | 1–1.5 mg/kg/hr (max 2 mg/kg/hr)              |
| Ventilation                | TV 6–8 mL/kg IBW, ETCO₂ 32–38 mmHg           |
| Hemodynamics               | SBP >90, treat hypotension with phenylephrine/ephedrine |

**Additional analgesia:** Surgeon local infiltration strongly encouraged (0.25% bupivacaine with epinephrine)

---

## PONV Prophylaxis (Give to All Patients)
- Ondansetron 4 mg IV  
- Dexamethasone 8 mg IV (at induction)  
- Scopolamine patch (if high-risk or history of severe PONV)  
- **No nitrous oxide**

---

## Emergence
1. Stop dexmedetomidine → 15 min before end  
2. Stop lidocaine infusion  
3. Sugammadex (if rocuronium used) or neostigmine  
4. Extubate awake / remove LMA when following commands  
→ Expect **calm, comfortable wake-up** with pain ≤3/10

---

## PACU Orders (Non-Opioid First)
- Acetaminophen 1000 mg IV/PO q6h  
- Ketorolac 15–30 mg IV q6h × 48h (if no contraindication)  
- Ice packs to chest  
- Ondansetron 4 mg IV PRN  
- **Opioids only if pain >6/10 and refractory**

---

## Documentation Template (Copy-Paste into Record)
## Documentation Template (Copy-Paste into Anesthesia Record)

```text
Block: [ ] PECS I+II   [ ] Serratus   Local anesthetic: _______________   Total vol: ___ mL
Additives: [ ] Dexamethasone 4 mg per side
Infusions: [ ] Dexmedetomidine (rate ____ mcg/kg/hr)   [ ] Lidocaine (rate ____ mg/kg/hr)
Intraoperative opioids: None
PONV prophylaxis: Ondansetron 4 mg, Dexamethasone 8 mg, [ ] Scopolamine patch
Airway: [ ] LMA   [ ] ETT
Emergence: Smooth, pain score __/10 on arrival to PACU
```

---

**End of Protocol 1** — *Educational resource only. Adapt to institutional and attending preferences.*

---
